Failure of GPI compounds to display neurotrophic activity in vitro and in vivo.
about
FK506-binding protein 12 ligands: a patent review.A review of research endeavors to optimize peripheral nerve reconstruction.Neurodegeneration and neuroprotection in Parkinson disease.Binding of rapamycin analogs to calcium channels and FKBP52 contributes to their neuroprotective activities.The effects of cold preservation and subimmunosuppressive doses of FK506 on axonal regeneration in murine peripheral nerve isograftsHigh-throughput fluorescence polarization method for identification of FKBP12 ligands.
P2860
Failure of GPI compounds to display neurotrophic activity in vitro and in vivo.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Failure of GPI compounds to display neurotrophic activity in vitro and in vivo.
@en
Failure of GPI compounds to display neurotrophic activity in vitro and in vivo.
@nl
type
label
Failure of GPI compounds to display neurotrophic activity in vitro and in vivo.
@en
Failure of GPI compounds to display neurotrophic activity in vitro and in vivo.
@nl
prefLabel
Failure of GPI compounds to display neurotrophic activity in vitro and in vivo.
@en
Failure of GPI compounds to display neurotrophic activity in vitro and in vivo.
@nl
P2093
P1476
Failure of GPI compounds to display neurotrophic activity in vitro and in vivo.
@en
P2093
Klitgaard H
P304
P356
10.1016/S0014-2999(01)00850-0
P407
P577
2001-03-01T00:00:00Z